Zoltán H Endre1, John W Pickering. 1. Department of Medicine, Christchurch Kidney Research Group, University of Otago, Christchurch, New Zealand. Rowena.fisher@otago.ac.nz
Abstract
BACKGROUND: The risk, injury, failure, loss-of-function, end-stage-renal-failure (RIFLE) and acute kidney injury network (AKIN) consensus definitions of acute kidney injury (AKI) were established in part to facilitate comparison of trials. Contrast-induced nephropathy (CIN) has traditionally used a less demanding definition. OBJECTIVES: To review use of RIFLE and AKIN as AKI trial outcome variables and contrast these with outcomes for CIN. METHODS: We conducted a search of PubMed from 1 January 2005 to 31 December 2008 and 9 trial registries for randomized control trials for preventional or interventional treatment of AKI and CIN. RESULTS: RIFLE or AKIN were outcome variables in 36% (n = 8) of the published (n = 22) and 18% (n = 4) of the current (n = 22) AKI trials. RIFLE was used to triage to intervention in three trials. The urine output definition of RIFLE and AKIN was an outcome in only two trials. In 18% (n = 8) of AKI trials, the CIN definition (increase in serum creatinine of > or =25% and/or > or =44 micromol/l) was the primary outcome. This was also the primary outcome in 56% (n = 13) of published (n = 12) and current (n = 11) CIN trials. Three published CIN trials used RIFLE or AKIN as an outcome (13%). The duration over which outcomes were determined varied from 24 h to 7 days. CONCLUSIONS: Considerable heterogeneity remains in outcome variables of AKI and CIN clinical trials. Even when the RIFLE or AKIN criteria were used, they were not applied consistently. There is a need for further consensus on surrogate outcome variables.
BACKGROUND: The risk, injury, failure, loss-of-function, end-stage-renal-failure (RIFLE) and acute kidney injury network (AKIN) consensus definitions of acute kidney injury (AKI) were established in part to facilitate comparison of trials. Contrast-induced nephropathy (CIN) has traditionally used a less demanding definition. OBJECTIVES: To review use of RIFLE and AKIN as AKI trial outcome variables and contrast these with outcomes for CIN. METHODS: We conducted a search of PubMed from 1 January 2005 to 31 December 2008 and 9 trial registries for randomized control trials for preventional or interventional treatment of AKI and CIN. RESULTS: RIFLE or AKIN were outcome variables in 36% (n = 8) of the published (n = 22) and 18% (n = 4) of the current (n = 22) AKI trials. RIFLE was used to triage to intervention in three trials. The urine output definition of RIFLE and AKIN was an outcome in only two trials. In 18% (n = 8) of AKI trials, the CIN definition (increase in serum creatinine of > or =25% and/or > or =44 micromol/l) was the primary outcome. This was also the primary outcome in 56% (n = 13) of published (n = 12) and current (n = 11) CIN trials. Three published CIN trials used RIFLE or AKIN as an outcome (13%). The duration over which outcomes were determined varied from 24 h to 7 days. CONCLUSIONS: Considerable heterogeneity remains in outcome variables of AKI and CIN clinical trials. Even when the RIFLE or AKIN criteria were used, they were not applied consistently. There is a need for further consensus on surrogate outcome variables.
Authors: Matthew J Page; Joanne E McKenzie; Sally E Green; Dorcas E Beaton; Nitin B Jain; Mario Lenza; Arianne P Verhagen; Stephen Surace; Jessica Deitch; Rachelle Buchbinder Journal: J Clin Epidemiol Date: 2015-06-16 Impact factor: 6.437
Authors: Zoltán H Endre; John W Pickering; Robert J Walker; Prasad Devarajan; Charles L Edelstein; Joseph V Bonventre; Christopher M Frampton; Michael R Bennett; Qing Ma; Venkata S Sabbisetti; Vishal S Vaidya; Angela M Walcher; Geoffrey M Shaw; Seton J Henderson; Maryam Nejat; John B W Schollum; Peter M George Journal: Kidney Int Date: 2011-02-09 Impact factor: 10.612
Authors: Steven G Coca; Girish N Nadkarni; Amit X Garg; Jay Koyner; Heather Thiessen-Philbrook; Eric McArthur; Michael G Shlipak; Chirag R Parikh Journal: PLoS One Date: 2016-08-18 Impact factor: 3.240
Authors: Werner Ribitsch; Gernot Schilcher; Franz Quehenberger; Stefan Pilz; Rupert H Portugaller; Martini Truschnig-Wilders; Robert Zweiker; Marianne Brodmann; Philipp Stiegler; Alexander R Rosenkranz; John W Pickering; Joerg H Horina Journal: Sci Rep Date: 2017-01-27 Impact factor: 4.379